Whereas the classical histological hallmarks of Alzheimer's disease (AD) are deposition of amyloid-containing plaques and development of neurofibrillary tangles, there is also clear evidence of inflammatory changes accompanied by the presence of activated microglia and astrocytosis. However, at this time it remains uncertain whether inflammatory changes contribute to pathogenesis of the disease or if they are secondary to deposition of amyloid-β or other pathological changes. A greater understanding of the sequence of events would clearly improve development of strategies to delay progression of the disease. There is a realistic expectation that advances in imaging technology may provide the key to uncovering this sequence. In this study, we employed non-invasive imaging techniques to examine changes in tissue state in hippocampus and cortex of transgenic mice which overexpress amyloid precursor protein and presenilin 1 and show that the observed increase in T 1 relaxation time was associated with astrogliosis while the decrease in T 2 relaxation time was associated with microglial activation. We explored the possibility that interferon-γ might trigger glial activation and demonstrate a genotyperelated infiltration of macrophages and natural killer cells, which release interferon-γ. The evidence suggests that IFNγ triggers glial activation and expression of proinflammatory cytokines, and these changes, in turn, contribute to the decrease in long-term potentiation.
INTRODUCTION
The deposition of amyloid-β (Aβ) in the brain is considered by several research teams as a potential trigger for a sequence of events which eventually leads to synaptic and neuronal dysfunction, and the consequent impaired cognitive function which characterizes Alzheimer's disease (AD). In AD and animal models of the disease, Aβ plaques are decorated by activated glia and some groups have interpreted this finding as an indication that Aβ increases activation of both microglia and astrocytes; this is supported by the fact that Aβ induces microglial activation and triggers astrocytosis in vitro, an effect mimicked by Aβ injection in vivo [1, 2] . However, it has also been proposed that inflammatory changes, consequent upon persistent glial activation, may contribute to the early pathogenic changes [3] . Thus the inflammatory cytokines TNFα and IL-1β, which are released from activated glia, increase γ-secretase activity [4] while expression of amyloid precursor protein (APP) and β-secretase are also increased by inflammatory cytokines [5] . A specific role for IL-1β is suggested by the finding that a blocking antibody reduces Aβ accumulation in a triple transgenic mouse model of AD [6] . These reports suggest that glial activation may contribute to the pathology and are consistent with the idea that 'inflammaging' may constitute a prodromal AD condition [7] . However this view may also imply that the ability of microglia to adopt their deactivated or alternatively activated states may be altered, perhaps due to decreased expression of factors which induce a shift in activation states such as NADPH oxidase [8] or increased signalling through toll-like receptors which prevents microglia adopting an immunoregulatory phenotype [9] .
One of the major challenges in neuroscience is to identify a mechanism by which these changes can be non-invasively recognized to permit early intervention and maximize the chance of impeding progression from prodromal conditions to AD. In this context, magnetic resonance imaging (MRI) has been a key development and combined analysis of changes in different parameters and histological changes in animal models of AD has provided some understanding of the anatomical correlates which underlie specific changes. Relaxometry, which measures the time taken to return to the baseline energy state following removal of the radio frequency pulse, is a powerful tool in the analysis of tissue states; T 1 relaxation time increases in conditions where there is axonal loss [10] or increased tissue water [11] , whereas decreased T 2 relaxation time is associated with iron deposition in tissue [12] [13] [14] . Changes in both have been linked with activation of glia following acute ischaemic insult with evidence of an increase in T 1 relaxation time correlating with astrocytosis [15] and a decrease in T 2 relaxation correlating with microglial activation [16] .
Here we set out to assess whether the predicted activation of astrocytes and microglia in APP/PS1 mice might be accompanied by changes in T 1 and T 2 relaxometry and to assess whether glial activation might be triggered by infiltration of cells which might induce an inflammatory microenvironment.
METHODS

Animals
Groups of 13-14 month-old (weighing 31g-56g) APPswe/PS1dE9 mice and wildtype littermate controls were used in this study. Mice purchased from the Jackson Laboratory (US) were used to form breeding pairs with C57BL/6 mice and were bred in an SPF housing facility in the Bio-resources Unit, Trinity College, Dublin. In one experiment, wildtype mice were anaesthetized with an intraperitoneal injection of Avertin (20µl/g; Sigma Aldrich, Ireland) and injected intracerebroventricularly with IFNγ (5µl;; 50ng/ml in PBS) or an equivalent volume of saline and, 4 hours later, were killed by decapitation.
Tissue was taken for preparation of cryostat sections (see below) and mRNA analysis. 
MRI
MRI analysis was carried out on a small rodent Bruker Biospec (Bruker Biospin, Germany) system with a 7 Tesla magnet and a 30 cm core to evaluate T 1 and T 2 relaxation times. Mice were anaesthetized using isoflurane, placed into an MR-compatible cradle and positioned in a stereotaxic frame. Anaesthesia was maintained by delivery of a mixture of isoflurane and oxygen administered by mechanical ventilator (1.5 -2 % at 1 litre/minute of 100% oxygen). Respiration rate was monitored and body temperature was controlled throughout.
A rapid acquisition with relaxation enhancement (RARE) with variable repetition time (RARE-VTR) scan was employed to assess T 1 relaxation times; the scan time was 8 minutes, 43 between the two types of relaxometry assessed in this study. The raw data from the T 2 MSME scan were exported to Interactive Data Language (IDL) and analysed using an inhouse scripting procedure, producing a voxelwise linear fitting to the logarithm of the data on the entire data set. The middle 5 echo times were used to create a parametric, quantitative T 2 map that was exported to ImageJ. ROIs were drawn with reference to a standardised mouse brain atlas (Paxinos and Franklin, 1995) and T 2 relaxation times calculated bilaterally for each hemisphere in 2 adjacent slices, and averaged for each mouse.
Analysis of LTP
A separate cohort of 14 month-old wildtype and APP/PS1 mice were used for preparation of hippocampal slices and analysis of LTP as previously described [17] . Briefly, hippocampal slices (400μm) were maintained at room temperature 
Detection of SDS-soluble and insoluble Aβ
Soluble and insoluble Aβ were extracted from snap-frozen brain tissue. Tissue was homogenized in 5 volumes (w/v) buffer (50mM NaCl, 1% SDS (w/v), pH10) containing phosphatase and protease inhibitor cocktails (Sigma, UK) and centrifuged at 15,000rpm for 40 minutes at 4 C. SDS-soluble Aβ was assessed in supernatant and insoluble Aβ isolated from the pellets using 5M guanidine. Soluble Aβ concentrations were assessed using 96-well multi-spot 4G8 Aβ triple ultra-sensitive assay kits (MesoScale Discovery, USA).
Plates were read using a sector Imager plate reader and concentration of Aβ in the samples determined with reference to the standard curve prepared using recombinant Aβ 1-38 , Aβ and Aβ 1-42. Concentrations of Aβ in serum were determined and calculated using the same method described above except that Blocker G was omitted from the detection antibody solution.
Analysis of cytokines
IL-1β, TNFα, IL-2, IL-12p70 and IFNγ were assessed using Multi-plex TH1/TH2 plates (MesoScale Discovery, US). Briefly, tissue was homogenized (SDS/NaCl, pH 10), centrifuged at 15,000rpm for 40 minutes at 4 C and the supernatant sample was taken for cytokines analysis. 96 well plates were blocked, washed, and detection antibody added according to the manufacturer's instructions. Samples, or standards (0-10,000 pg/ml), prepared in 1% Blocker A solution, were added, incubation proceeded for 2 hours at room temperature and plates were washed. Read buffer was added and the plate was read immediately using a Sector Imager plate reader. Cytokine concentrations were evaluated with reference to the standard curves.
Immunohistochemistry
Cryostat sections from APP/PS1 and wildtype mice were prepared for CD11b and GFAP staining as previously described [18] . Sections were incubated initially in the presence of 
PCR analysis of markers of glial activation
RNA was isolated from cortical brain tissue using Nucleospin® RNAII KIT (MachereyNagel, Duren, Germany) and cDNA was prepared using High-Capacity cDNA RT kit , where CT is threshold cycle).
Flow Cytometry
Whole brain tissue from one hemisphere was harvested in Hank's Balanced Salt Solution (HBSS) containing 3% fetal bovine serum (FBS), dissociated through a cell strainer (70μm) and centrifuged at 170 x g for 10 minutes. The pellet was resuspended in PBS containing collagenase D (1mg/ml) and DNAse I (10μg/ml), incubated for 30 minutes at 37°C with gentle agitation and centrifuged at 170 x g for 10 minutes. Cells were resuspended in 1.088 g/ml Percoll (9ml), underlaid with 1.122 g/ml Percoll (5ml), overlaid with 1.072 g/ml Percoll (9ml), 1.030 g/ml Percoll (9ml) and PBS (9ml) and centrifuged at 1250 x g for 45 minutes. Mononuclear cells, harvested at the 1.088:1.072g/ml and 1.072:1.030g/ml interfaces were removed, washed 3 times with FACS buffer (2% FBS, 0.1% NaN 3 in PBS) and blocked for 15 minutes with mouse Fc block (BD Biosciences, UK). Cells were incubated with allophycocyanin rat anti-mouse CD11b, PE-Cy™7 rat antimouse CD45, PE-Cy™5 CD8 and phycoerythrin rat anti-mouse NKp46 (all BD Biosciences, UK) and Alexa Fluor 488 rat anti-mouse CD68 (AbD Serotec, UK), diluted and 50 U/ml penicillin/streptomycin (Invitrogen, UK). To prepare purified microglia, cells were grown in T25 flasks in DMEM. After 12 days the flasks were shaken for 2 hours at 110 rpm, at room temperature and tapped several times to remove non-adherent microglia.
The supernatants were removed from the flask and centrifuged at 2000 rpm for 3 minutes at 21°C. The pellet was resuspended in DMEM and the cells were counted. Cells were pipetted into 6 well plates at a density of 5x10 4 cells/cm 2 . Isolated microglia were treated with IFN (50ng/ml) or vehicle for 24 hours after which time supernatant concentrations of TNF and IL-6 were assessed by ELISA and cell surface expression of CD11b, CD86 and MHC11 was assessed by flow cytometry.
RESULTS
We used MRI to compare T 2 relaxation time in the brains of wildtype and APP/PS1 mice.
The colour-enhanced images indicate marked differences in several areas of the brain of APP/PS1 ( Figure 1B ), compared with wildtype ( Figure 1A ), mice and quantitative analysis revealed a significant decrease in T 2 relaxation time in cortex and hippocampus of APP/PS1 mice (*p < 0.05;; ***p < 0.001;; Student's t-test for Independent means; Figure   1C ,D). Analysis of data from other areas of the brain indicate that no significant changes were observed in corpus callosum or thalamus, but were generally confined to cortical and hippocampal regions (Table 2) . We, and others, have reported that increased microglial activation is associated with decreased T 2 relaxation time [16, 18] and this finding is confirmed here. Thus increased CD11b immunoreactivity was observed in sections prepared from APP/PS1 ( Figure 1F and H), compared with wildtype, (E and G) mice and similar increases were identified in cortex ( Figure 1E ,F) and hippocampus ( Figure 1G,H) ;
there was a significant increase in the ratio of DAB/nuclear area in cortex and hippocampus (**p < 0.01;; Student's t-test for Independent means; Figure 1I ,J respectively). Significant (Table 2) . A correlation between astroglial activation and T 1 relaxation time has been reported in animals following acute ischaemic injury [15] and in aged animals [20] and the present data confirm this correlation. Thus GFAP immunoreactivity, which is an indicator of astrocytic activation, was markedly increased in sections prepared from the cortex of APP/PS1 mice ( Figure 2F ) compared with wildtype mice ( Figure 2E ). Similarly, marked GFAP immunoreactivity was observed in hippocampus of APP/PS1 mice compared with wildtype mice (Figure 2 ; compare H with G); there was a significant increase in the ratio of DAB/nuclear area in cortex and hippocampus (***p < 0.001; Student's t-test for Independent means; Figure 2I ,J respectively). Consistently, GFAP mRNA was also increased in cortex of APP/PS1 mice compared with wildtype mice (***p < 0.001;; Student's t-test for Independent means; Figure 2K ).
Activated microglia and astrocytes produce inflammatory cytokines and the genotypeassociated glial activation described here was associated with increased hippocampal concentrations of IL-1β, TNFα, IL-2 and IL-12 (*p < 0.05; **p < 0.01; ***p < 0.001; Figure 4A ). One possible explanation for this is that there was significant infiltration of NK cells into the CNS in APP/PS1 mice (***p < 0.001;; Student's t-test for Independent means; Figure 4B ). There was also a 4-fold increase in CD11b + CD45 + macrophages in tissue prepared from APP/PS1, compared with wildtype, mice (***p < 0.001;; Student's t-test for Independent means; Figure 4C ) and the proportion of these cells which expressed CD68 was also significantly greater in APP/PS1 mice (**p < 0.01;
Student's t-test for
Student's t-test for Independent means; Figure 4D ).
To assess the possible role of IFNγ in triggering microglial activation, a cohort of wildtype mice were injected intracerebroventricularly with IFNγ (5µl;; 50ng/ml in PBS) and assessed 4 hours later for evidence of glial activation. IFNγ increased CD11b and GFAP immunoreactivity in hippocampus ( Figure 5A and C respectively) and also increased mRNA expression of the microglial marker, MHCII (**p < 0.01;; Student's t-test for Independent means; Figure 5B ) and the astroglial marker, GFAP (*p < 0.05;; Student's ttest for Independent means;; Figure 5D ). Significant IFNγ-induced increases in mRNA expression of 2 inflammatory cytokines, TNFα and IL-6 were also observed (*p < 0.05;
Student's t-test for Independent means; Figure 5E,F). Importantly, LTP recorded from
hippocampal slices in the presence of IFNγ (1µg/ml) was significantly reduced, relative to that recorded under control conditions (p < 0.01;; Student's t-test for Independent means; Figure 5G ).
To ensure changes observed in microglial activation occurred due to the presence of IFNγ, primary microglia were prepared and treated with IFNγ (50ng/ml) for 24 hours ( Figure 6 ). Treatment of isolated microglia with IFNγ significantly enhanced the expression of cell surface molecules such as CD86 and MHCII (**p < 0.01;; Student's t-test for Independent means; Figure 6A and B respectively) and the release of proinflammatory cytokines TNFα and IL-6 (***p < 0.001;; Student's t-test for Independent means; Figure 6C and D respectively). These results parallel those observed in vivo.
DISCUSSION
Glial activation is a consistently-described feature of AD and animal models of the disease but the trigger responsible for glial activation is unclear. In this study we have identified a potential sequence of events, initiated by infiltration of IFNγ-producing cells, which leads to this change and ultimately exerts a negative impact on LTP. The data describe a relationship between microglial activation and T 2 relaxation time, and astroglial activation and T 1 relaxation time, opening the possibility that development of changes in microglial activation may be tracked non-invasively particularly as age-related decreases in T 2 relaxation times closely paralleled age-related increases in CD11b immunoreactivity.
Aβ accumulation is detectable in the brain of APP/PS1 transgenic mice at an early age [23] and increases with age [24] . Predictably, increased concentrations of soluble and insoluble Aβ 1-40 and Aβ were evident throughout the brain in the 14 month-old APP/PS1 mice used in this study, as reported by others [25, 26] . Accumulation of Aβ in the brain of APP/PS1 mice is accompanied by several changes including microglial activation [12, 27] and CD11b immunoreactivity and CD11b mRNA were markedly enhanced in tissue prepared from APP/PS1 mice used in the present study; an increase in the number of CD11b-positive cells which expressed CD68 was also demonstrated in tissue prepared from APP/PS1 mice.
Microglial activation in APP/PS1 mice has been identified by an increased Iba1 immunoreactivity [28] , coupled with increased [ 11 C](R)-PK11195 binding as revealed by positron emission tomography PET [29] and the present data show that it was also associated with a decrease in T 2 relaxation time. An inverse correlation between T 2 relaxation and microglial activation has been observed in different models of inflammation, including aged animals [16, 18, 30] . Accumulation of iron, which occurs in activated microglia, at least in APP/PS1 mice [12] , is considered to contribute to the change in T 2 relaxation time [31] , although the combination of iron accumulation and Aβ deposition may be particularly important in inducing the change [31, 32] . GFAP immunoreactivity, which is indicative of astrocytic activity, was also increased in APP/PS1 mice which concurs with previous data [33] . Here, the GFAP immunoreactivity was accompanied by an increase in T 1 relaxation time and this is consistent with the previously-reported positive correlation between astrocytic activation and T 1 relaxation time in aged animals [20] and following acute insult [15] .
Both Aβ accumulation and glial activation have been associated with deficits in neuronal function; for example, spatial learning is impaired in some transgenic models of AD including APP/PS1 mice [27, 34, 35] , and impaired spatial learning also accompanies glial activation, for example in aged animals [20] , LPS-treated animals [36] and Aβ-treated animals [37, 38] . LTP is also decreased in each of these conditions [20, [39] [40] [41] and some, but not all researchers, report that LTP is decreased in APP/PS1 mice [25, 39, 42, 43] . The present data indicate that LTP induced by theta-burst stimulation was markedly decreased in area CA1 of 14 month-old APP/PS1 mice and this was associated with increased expression of the inflammatory cytokines IL-1β, TNFα and IL-2, all of which exert a negative impact on LTP [20] [21] [22] . Increased expression of inflammatory cytokines commonly accompanies glial activation and both have been associated with increased Aβ accumulation and deficits in synaptic plasticity observed in APP/PS1 mice [12, 27] . Indeed modulation of microglial activation by knocking out CD40 [44] or by treating mice with rosiglitazone [27] or polyunsaturated fatty acids [45] , which decrease microglial activation [20, 41, 46] , improves spatial learning in models of AD. Despite these findings and the likelihood that inflammation plays a role in the early stages of AD, modulation of glial activation is not therapeutically valuable in established AD although its benefit, if any, in very early prodromal conditions remains to be determined.
One of the most potent activators of microglia is IFNγ [47, 48] , but there is little evidence to suggest that it is released from resident cells in the brain. Here we demonstrate that glial activation is associated with infiltration of macrophages and NK cells, both of which release IFNγ in response to IL-12 and IL-2, as well as IL-18 [49] [50] [51] ; significantly, concentrations of both IL-12 and IL-2 were increased in tissue prepared from APP/PS1 mice, therefore, these infiltrating cells may be the source of the increase in IFNγ concentration in the brain of APP/PS1 mice providing the trigger for microglial activation and the consequent decrease in LTP. While an intact BBB provides one of the most important protective strategies for the brain limiting the entry of cells and preventing the entry of high molecular molecules, the evidence has indicated that its permeability is increased in AD [52, 53] and in mouse models of AD [54, 55] , perhaps as a consequence of amyloidogenesis [56] since the age-related increase in fluorescence was magnified by the presence of Aβ plaque deposition in AD mice.
To assess whether IFNγ might provide the trigger for glial activation in this study, the effects of intracerebroventricular injection of IFNγ were evaluated and the data demonstrate that IFNγ increases activation of both microglia and astrocytes and is associated with increased expression of inflammatory cytokines. IFNγ also decreases LTP which concurs with earlier data indicating that IFNγ inhibited LTP in dentate gyrus of urethane-anaesthetized rats [57, 58] and with the observation that when hippocampal concentration of IFNγ is decreased, LTP is sustained [40] . Additionally, incubation of primary isolated microglia with IFNγ showed similar effects in terms of proinflammatory cytokine release and the cell surface expression of the co-stimulatory molecule CD86 and MHCII which are important in microglial activation. Therefore these data suggest that
IFNγ, probably derived from infiltrating cells has a detrimental effect, but it is important to note that a protective effect of infiltrating leukocytes has been reported [59] , while infiltrating macrophages have been shown to limit Aβ accumulation [60] .
It is not clear whether microglial activation precedes or follows Aβ deposition. Aβ certainly induces microglial activation in vivo and in vitro [1, 61] and it has been reported that MHCII immunoreactivity follows plaque formation in APP/PS1 mice [62] although
CD11b immunoreactivity appears to coincide with plaque development in APPoverexpressing mice [63] . However, chronic inflammatory changes, presumably accompanied by glial activation, may precipitate Aβ deposition [64] , whereas TNFα and IL-1β, which are released from activated microglia, increase activity and/or expression of γ-and β-secretases [4, 5] which ultimately leads to Aβ deposition. Careful longitudinal studies are necessary to establish the sequence of events and this may be facilitated by MRI analysis of T 1 and T 2 relaxation times.
The evidence supports the hypothesis that infiltration of peripheral cells, specifically macrophages and NK cells, is likely to contribute to the inflammatory microenvironment in the brain, perhaps by providing a source of IFNγ which triggers glial activation and release of inflammatory mediators that ultimately negatively impact on synaptic plasticity. 
